X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs GSK PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA GSK PHARMA FULFORD INDIA/
GSK PHARMA
 
P/E (TTM) x 398.8 60.1 663.2% View Chart
P/BV x 6.2 11.8 52.7% View Chart
Dividend Yield % 0.1 2.1 4.0%  

Financials

 FULFORD INDIA   GSK PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
GSK PHARMA
Mar-16
FULFORD INDIA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs9423,850 24.5%   
Low Rs4502,966 15.2%   
Sales per share (Unadj.) Rs691.4332.3 208.0%  
Earnings per share (Unadj.) Rs11.544.3 25.9%  
Cash flow per share (Unadj.) Rs15.447.2 32.5%  
Dividends per share (Unadj.) Rs2.0050.00 4.0%  
Dividend yield (eoy) %0.31.5 19.6%  
Book value per share (Unadj.) Rs380.0202.7 187.4%  
Shares outstanding (eoy) m3.9084.70 4.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.010.3 9.8%   
Avg P/E ratio x60.776.9 78.9%  
P/CF ratio (eoy) x45.372.2 62.8%  
Price / Book Value ratio x1.816.8 10.9%  
Dividend payout %17.4112.9 15.5%   
Avg Mkt Cap Rs m2,714288,643 0.9%   
No. of employees `0000.44.6 9.6%   
Total wages/salary Rs m5054,434 11.4%   
Avg. sales/employee Rs Th6,073.06,104.5 99.5%   
Avg. wages/employee Rs Th1,137.4961.6 118.3%   
Avg. net profit/employee Rs Th100.7813.7 12.4%   
INCOME DATA
Net Sales Rs m2,69628,148 9.6%  
Other income Rs m1251,218 10.3%   
Total revenues Rs m2,82229,366 9.6%   
Gross profit Rs m-464,774 -1.0%  
Depreciation Rs m15248 6.1%   
Interest Rs m100-   
Profit before tax Rs m545,744 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m026 0.0%   
Tax Rs m102,018 0.5%   
Profit after tax Rs m453,752 1.2%  
Gross profit margin %-1.717.0 -10.1%  
Effective tax rate %17.735.1 50.3%   
Net profit margin %1.713.3 12.4%  
BALANCE SHEET DATA
Current assets Rs m1,73821,462 8.1%   
Current liabilities Rs m54510,536 5.2%   
Net working cap to sales %44.338.8 114.0%  
Current ratio x3.22.0 156.7%  
Inventory Days Days4868 71.6%  
Debtors Days Days416 26.2%  
Net fixed assets Rs m124,717 0.3%   
Share capital Rs m39847 4.6%   
"Free" reserves Rs m1,44316,308 8.8%   
Net worth Rs m1,48217,171 8.6%   
Long term debt Rs m016 0.0%   
Total assets Rs m2,07730,620 6.8%  
Interest coverage x6.7NM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.9 141.2%   
Return on assets %2.612.3 21.3%  
Return on equity %3.021.9 13.8%  
Return on capital %4.333.6 12.8%  
Exports to sales %00 0.0%   
Imports to sales %24.515.1 162.4%   
Exports (fob) Rs mNA4 0.0%   
Imports (cif) Rs m6594,237 15.6%   
Fx inflow Rs m17519 3.3%   
Fx outflow Rs m6738,320 8.1%   
Net fx Rs m-656-7,801 8.4%   
CASH FLOW
From Operations Rs m901,386 6.5%  
From Investments Rs m1055,010 2.1%  
From Financial Activity Rs m-14-6,383 0.2%  
Net Cashflow Rs m18112 1,529.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 50.7 147.9%  
Indian inst/Mut Fund % 3.8 10.2 37.3%  
FIIs % 0.1 23.8 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 15.4 137.7%  
Shareholders   4,783 102,036 4.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   SUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  UNICHEM LAB  MERCK LTD  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS